en · de · es · fr · pt
sr9009-notes.peptides4088.com › News › Analytical Detection And Laboratory Handling — Deep Dive

Analytical Detection And Laboratory Handling — Deep Dive

By Editorial Desk · published 2026-04-04 · last reviewed 2026-05-16 · News

certificate of analysis is one of those subjects where the details matter more than the headlines. This page pulls together the background, the mechanisms, and the practical points readers ask about most.

Updated 2026-05-16. Numbers and descriptions here follow the published literature rather than marketing material.

Analytical Detection and Laboratory Handling

Detection in biological samples can be complicated by rapid metabolism and low circulating concentrations. Some studies report phase I and phase II metabolites, and analytical methods may need to target those species in addition to the parent compound. Immunoassays are not broadly available, so mass spectrometry remains the main confirmatory approach. For anti-doping testing, laboratories look for SR9009 and its metabolites using validated LC-MS methods. Open questions include how long metabolites remain detectable and how different routes of administration alter detection windows.

In laboratory settings, SR9009 is typically characterized by liquid chromatography–mass spectrometry (LC-MS) or high-performance liquid chromatography with ultraviolet detection (HPLC-UV). These methods can confirm identity and estimate purity, but they require reference standards for accurate quantification. Because SR9009 is not a licensed pharmaceutical, no harmonized pharmacopeial monograph exists. Laboratories often validate in-house methods for matrices such as plasma, urine, or cell culture media. Sample preparation may involve protein precipitation or liquid-liquid extraction before analysis.

SR9009 Background and Mechanism

Pharmacokinetic data for SR9009 are limited in published literature. Some reports indicate low oral bioavailability and rapid clearance in animals, which complicates interpretation of exposure and effect. Researchers often use injected routes in preclinical work to achieve measurable systemic levels. Analytical studies rely on mass spectrometry to detect the parent compound and its metabolites. Questions about tissue distribution, active metabolites, and long-term consequences remain open. Species differences in metabolism can affect observed half-life and target engagement.

SR9009 is a synthetic small molecule studied as an agonist of the nuclear receptors REV-ERBα and REV-ERBβ. These receptors help regulate circadian rhythms and metabolic gene expression. In laboratory experiments, SR9009 binds these receptors and alters transcription of genes involved in lipid handling, glucose metabolism, and mitochondrial function. It is not a naturally occurring compound and has no approved therapeutic use. Research interest stems from its ability to modify energy metabolism in cells and animal models.

Sr9009 at a glance

PropertyValueNotes
AppearanceOff-white to pale yellow solidVisual description varies with purity and source
SolubilitySoluble in DMSO and ethanol; poorly soluble in waterOrganic stock solutions are common in research
Typical storage-20 °C, desiccated, protected from lightAvoid repeated freeze-thaw cycles
Typical analytical methodLC-MS or HPLC-UVReference standards are needed for quantification
Molar massApproximately 437.9 g/molCalculated from the reported free-base formula

Analytical Detection and Storage

Quality control for research materials includes identity confirmation by nuclear magnetic resonance and purity assessment by high-performance liquid chromatography. Mass spectrometry provides molecular weight confirmation and can detect related impurities. Purchasers should request a certificate of analysis that lists lot-specific data. Online products advertised for human use often lack such documentation. Distinguishing legitimate research material from mislabeled or contaminated samples is a recurring challenge in independent testing, and independent laboratories may use orthogonal methods to verify identity.

Detection of SR9009 in biological samples usually relies on liquid chromatography coupled to tandem mass spectrometry. This approach separates the compound from matrix components and identifies it by mass transitions. Because SR9009 can undergo metabolism, laboratories often look for both parent drug and specific metabolites. Sample preparation may involve protein precipitation or solid-phase extraction. Method validation examines sensitivity, carryover, and interference from related substances, and reference standards are required for accurate calibration.

Storage recommendations for SR9009 reference material typically specify a freezer at -20 °C or lower, with protection from moisture and light. Repeated freeze-thaw cycles can degrade small molecules and introduce variability. Stock solutions in dimethyl sulfoxide are often aliquoted to avoid repeated handling. Stability studies may examine degradation under heat, humidity, and light exposure. The compound's thiophene and nitro groups can participate in reactions that alter analytical signals over time, so such changes affect quantitative results.

Related pages on this site

Background and Research Status

REV-ERB proteins help regulate daily cycles in gene expression, including genes tied to lipid and glucose metabolism. SR9009 binds these receptors and alters their activity in cell and animal experiments. Consequences observed in rodents include changes in skeletal muscle oxidative capacity, blood lipid levels, and exercise performance. The precise chain from receptor occupancy to whole-body effects is still an active area of study. Human responses cannot be assumed from rodent data.

Most published work on SR9009 consists of preclinical studies. It is widely sold as a research chemical, a category that does not imply safety, efficacy, or pharmaceutical-grade quality. Sports anti-doping organizations have listed SR9009 as a prohibited substance, and its presence in an athlete sample can lead to sanctions. Legal status differs by country; in several jurisdictions it is not approved for human consumption and may be treated as an unapproved new drug.

SR9009 is a synthetic small molecule studied as an agonist of the nuclear receptors REV-ERBα and REV-ERBβ. It is not a steroid, peptide, or natural hormone. In scientific literature, it appears under the code SR9009 and in non-scientific contexts as Stenabolic. The compound was identified through chemical screening efforts aimed at targeting circadian clock components. Its status remains investigational, and no regulatory agency has approved it as a human medicine.

SR9009 Handling and Quality Control

SR9009 stability depends on temperature, moisture, light, and solvent. Solid material is generally kept cool and dry, while solutions may require protection from repeated warming and cooling. Degradation can appear as color changes, precipitate, or new chromatographic peaks. Researchers should follow supplier instructions and their own stability data. Long-term storage conditions for human use have not been established because the compound lacks approved clinical formulation.

SR9009 is supplied as a solid research chemical, often in milligram quantities. Laboratories typically weigh it in a controlled environment because fine powders can disperse. Stock solutions are commonly prepared in dimethyl sulfoxide and stored in small aliquots to reduce freeze-thaw cycles. Personal protective equipment and chemical fume hoods are standard when handling unknown or potent compounds. These practices address laboratory safety rather than human use.

Handling Storage and Quality Control

Storage conditions for research-grade SR9009 generally involve a freezer at approximately minus twenty degrees Celsius, sometimes lower for long-term preservation. Containers should remain tightly closed and protected from light. Desiccants may be used to limit moisture uptake. Solutions are often stored in aliquots to avoid repeated warming and cooling. Stability data for the compound under various conditions are limited, so laboratories typically follow supplier recommendations and verify performance through periodic analytical checks rather than assuming indefinite stability.

Identity and purity testing for SR9009 commonly uses liquid chromatography coupled with tandem mass spectrometry. This method separates the compound from matrix components and detects it by mass-to-charge transitions, providing sensitive and specific confirmation. Nuclear magnetic resonance spectroscopy can support structural identification, while high-performance liquid chromatography with ultraviolet detection may estimate purity. Because online products labeled as SR9009 may contain other substances or no active compound at all, independent verification is important in research settings. Certificates of analysis are useful but not a substitute for in-house testing.

Background from the literature

==== β1-selectivity ==== Bisoprolol β1-selectivity is especially important in comparison to other nonselective beta blockers. The effects of the drug are limited to areas containing β1 adrenoreceptors, which are mainly the heart and part of the kidney. Bisoprolol, whilst β1 adrenoceptor selective can help patients to avoid certain side-effects associated with non-selective beta-blocker activity at additional adrenoceptors (α1 and β2), it does not signify its superiority in treating beta-blocker indicated cardiac conditions such as heart failure but could prove beneficial to patients with specific comorbidities. Bisoprolol has a higher degree of β1-selectivity compared to atenolol, metoprolol and betaxolol. With a selectivity ranging from being 11 to 15 times more selective for β1 over β2. However, nebivolol is approximately 3.5 times more β1-selective.

Various medications are approved for treating obesity with varying rates of weight loss between 3-21%, but weight regain is very common after discontinuation. Medications are recommended to be used only in combination with lifestyle changes. After stopping treatment with GLP-1 agonists such as semaglutide, liraglutide and tirzepatide, people regain on average more than half (50–70%) of the lost weight within 1 year.

== Uses == P. rubens is the source of β-lactam antibiotics, principally of penicillins and to a lesser extent, cephalosporins. The species produces three penicillins, benzylpenicillin (G), phenoxymethylpenicillin (V) and octanoylpenicillin (K). Penicillin G is a naturally occurring compound that was first isolated and used as an antibiotic. Penicillins from P. rubens are effective against Gram-positive bacteria such as the species of Bacillus, Clostridium, Corynebacterium, Pneumococcus, Streptococcus, and Staphylococcus. They are clinically used to treat actinomycosis, anthrax, botulism, clostridial infections, diphtheria, empyema, endocarditis, food poisoning (due to Listeria), gas gangrene, meningitis, pneumonia, pericarditis, septicaemia, and syphilis. However, they are useless against Gram-negative bacteria since these bacteria are impermeable to the compounds because of their additional outer cell membrane, as well as some species producing pencillases (β-lactamases) that destroy the penicillin structure (β-lactam ring). However, semisynthetic penicillins like aminopenicillins (ampicillin, amoxicillin, and bacampicillin), carboxypenicillins (carbenicillin and ticarcillin) and ureidopenicillins (mezlocillin, azlocillin, and piperacillin) have been developed that are effective against these bacteria. Cephalosporins, naturally produced by other fungi belonging to the genus Acremonium, are one of the most widely used antibiotics by clinicians and is also produced by P. rubens. However, they are not naturally produced by P. rubens.

Glu-270 and Arg-127 play an important role in catalysis shown in Figure 2. Arg-127 acts to stabilize the carbonyl of the substrate that is bound to amino group of phenylalanine. Simultaneously, the water molecule coordinated to zinc is deprotonated by Glu-270 and interacts with the carbonyl stabilized by Arg-127. This creates an intermediate, shown in Figure 2, where the negatively charged oxygen is coordinated to zinc, and through unfavorable electrostatic interactions between Glu-270 and the ionized product facilitates the release of the product at the end of catalysis. In recent computational studies, the mechanism of catalysis is similar but the difference in mechanism is that deprotonated water molecule binds to the carbon of the carbonyl, whereas Figure 2 shows the hydroxyl group stays coordinated to zinc. Then proteolysis occurs and the water molecule is then introduced back into the active site to coordinate to zinc. Several studies have been conducted exploring the details of the bond between carboxypeptidase A and substrate and how this affects the rate of hydrolysis. In 1934, it was first discovered through kinetic experiments that, in order for substrate to bind, the peptide that is to be hydrolyzed must be adjacent to a terminal free hydroxyl group. Also, the rate of hydrolysis can be enhanced if the C-terminal residue is branched aliphatic or aromatic. However, if the substrate is a dipeptide with a free amino group, it undergoes hydrolysis slowly; this, however, can be avoided if the amino group is blocked by N-acylation.

=== Trademark lawsuit against Nike === In July 2026, 7-Eleven filed a trademark infringement lawsuit against Nike, Inc. in the United States District Court for the Northern District of Texas, seeking to block the release of a new Nike Air Max 95 "Big Bubble" sneaker. The complaint alleged that the shoe's colorway imitated, in a "confusingly similar" manner, the orange, green, and red color combination of the 7-Eleven logo, which the company has used commercially since the 1980s and for which it holds multiple federal trademark registrations. 7-Eleven argued that the design could mislead consumers into believing that Nike had a partnership or collaboration with the company, noting that some product listings and media outlets had referred to the sneaker as the "7-Eleven" shoe or described it as "7-Eleven-inspired". The complaint also pointed to the shoe's planned release date of July 11, which coincides with the company's annual "7-Eleven Day" promotion, as evidence of deliberate association. 7-Eleven asked the court for a permanent injunction barring the sale and promotion of the shoe, a recall and destruction of existing inventory, disgorgement of profits, and damages. According to federal court records, Nike was served with the complaint on July 6, 2026; a hearing date had not yet been scheduled.

Sources: en.wikipedia.org

Reference notes

Flowers removed from the plant remain alive. Respiration and photosynthesis continue, but no longer have a storehouse of sugars to support them. Additionally, the flowers no longer receive water from the roots, yet transpiration continues. In many countries, cut flowers are a local crop because of their perishable nature. In India, much of the product has a shelf life of only a day. Among these are marigold flowers for garlands and temples, which are typically harvested before dawn, and discarded after use the same day. The postharvest life or vase life of cut flowers can be several days. The vase life of cut flowers and cut greens can be extended with thoughtful care. This care starts from the moment of harvest and continues until they are enjoyed by a flower consumer. Everyone involved must participate in the, "Floral Chain-of-Life", or the life of the cut flowers and cut greens is reduced. Flowers are harvested in the cool part of the day, generally morning, and placed into water as soon as possible to reduce water loss from transpiration. The cut stems go into clean buckets with low pH water as a hydrating solution. Next, the cut stems are refrigerated to slow respiration, photosynthesis and transpiration. Vacuum coolers and hydrocoolers are used for large numbers of flowers on commercial farms. When cold, 2–4 °C (36–39 °F), the cut stems are sized and graded for shipment. Additionally, most or all of the leaves are removed from the cut flower stems to reduce the cost of shipping and reduce disease issues.

{\displaystyle {\begin{array}{lll}M({\ce {NaCl}})&=[22.98976928(2)+35.453(2)]\times M_{\text{u}}\\&=58.443(2){\text{ g/mol}}\\M({\ce {C12H22O11}})&=[12\times 12.0107(8)+22\times 1.00794(7)+11\times 15.9994(3)]\times M_{\text{u}}\\&=342.297(14){\text{ g/mol}}\end{array}}}

=== John-Daniel Stern === John-Daniel "JD" Stern (Adain Bradley) is Harper's estranged twin brother, who disappeared from her life when the two were teenagers. In series 2, Harper tracks down her brother to Berlin, where he works as a line cook. The two spend the night at a club, and the next morning, JD relapses on his meth addiction. The two have a vicious argument over their childhood growing up with an abusive mother; JD reveals he ran away in part due to Harper exacerbating the pressure their mother put on him to be a star tennis player, but Harper maintains that she too escaped a traumatic upbringing. Harper begs JD to come home with her, but rebuffs her, branding his sister a selfish narcissist who was complicit in the abuse he suffered. Harper is left deeply shaken by the encounter. In series 4, JD calls Harper to tell her that their mother died in a freak accident, having fallen down the stairs while collecting an Amazon delivery. Harper struggles to grieve her mother's death given her traumatic childhood, as well as her preoccupation with her work.

== Adverse effects == Although not as widely published as the beneficial, therapeutic effects of cannabis tea, adverse effects of consumption have been found to exist, in addition to the known adverse effects of cannabis use in general. Based upon the findings of select studies, it appears as though such effects occur mainly as a result of unconventional methods or dosage used when interacting with the decoction.

In February 1994 and September 1995, the Wake Shield Facility was carried into orbit by the Space Shuttle. This demonstration platform used the vacuum created in the orbital wake to manufacture thin films of gallium arsenide and aluminum gallium arsenide. On May 31, 2005, the recoverable, uncrewed Foton-M2 laboratory was launched into orbit. Among the experiments were crystal growth and the behavior of molten-metal in weightlessness. The completion of the International Space Station has provided expanded and improved facilities for performing industrial research. NASA and Tethers Unlimited will test the Refabricator aboard the ISS, which is intended to recycle plastic for use in space additive manufacturing. The Material Science Laboratory Electromagnetic Levitator (MSL-EML) on board the Columbus Laboratory is a science facility that can be used to study the melting and solidification properties of various materials. The Fluid Science Laboratory (FSL) is used to study the behavior of liquids in microgravity.

Sources: en.wikipedia.org

Frequently asked questions

How is SR9009 detected?

It is usually detected by LC-MS or HPLC-UV against a reference standard. In biological matrices, metabolite targeting can improve detection. No universal immunoassay is widely available.

What is known about its stability?

The compound is generally handled as light-sensitive and stored cold and dry. Stability in solution depends on solvent, concentration, and storage time. Specific degradation rates are not fully standardized.

Why does solubility matter?

Limited water solubility affects formulation for cell and animal studies. Organic co-solvents are often used to dissolve it. Precipitation can confound assay results if not controlled.

What is SR9009?

It is a synthetic research compound that activates REV-ERB nuclear receptors. It is not an approved drug or dietary supplement. Most information comes from cell and animal studies.

Network